Payment overview · 2025
General Payments
$14,440.20
118 reported records · 15 companies
Healthcare provider profile · identity verified
Truc Ta, M.D.
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · PORTLAND, ME · NPI 1114459831
Verified facts
What the public records show
CMS Open Payments records show Truc Ta, M.D. received $14,440.20 in general payments during 2025 across 118 reported records.
Boston Scientific Corporation accounted for 30.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 36 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $4,456.24 | 30.9% | 30 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $3,432.63 | 23.8% | 19 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$3,267.01 | 22.6% | 19 | 2025 |
| Integra LifeSciences Corporation | Unresolved — no canonical attribution shown | $988.17 | 6.8% | 11 | 2025 |
| Organogenesis Inc. | Unresolved — no canonical attribution shown | $560.62 | 3.9% | 11 | 2025 |
| LeMaitre Vascular, Inc. | Unresolved — no canonical attribution shown | $459.88 | 3.2% | 8 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $317.61 | 2.2% | 4 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $289.08 | 2.0% | 3 | 2025 |
| Davol Inc. | Unresolved — no canonical attribution shown | $223.54 | 1.6% | 2 | 2025 |
| Route 92 Medical, Inc. | Unresolved — no canonical attribution shown | $146.34 | 1.0% | 1 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $108.79 | 0.8% | 3 | 2025 |
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $95.95 | 0.7% | 2 | 2025 |
| Tactile Systems Technology Inc | Unresolved — no canonical attribution shown | $56.96 | 0.4% | 3 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $22.44 | 0.2% | 1 | 2025 |
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $14.94 | 0.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $6,473.04 | 89 |
| Travel and Lodging | $5,906.55 | 22 |
| Grant | $1,500.00 | 1 |
| Long term medical supply or device loan | $560.61 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $3,124.95 | 13 | 2025 |
Source payment records
|
|||||
| EkoSonic Normalized: ekosonic |
Device | Boston Scientific Corporation | $2,857.81 | 18 | 2025 |
Source payment records
|
|||||
| VALIANT CAPTIVIA Normalized: valiant captivia |
Device | Medtronic, Inc. | $1,448.75 | 12 | 2025 |
Source payment records
|
|||||
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $1,082.07 | 5 | 2025 |
Source payment records
|
|||||
| Cytal Normalized: cytal |
Device | Integra LifeSciences Corporation | $494.15 | 5 | 2025 |
Source payment records
|
|||||
| Integra Normalized: integra |
Device | Integra LifeSciences Corporation | $427.56 | 5 | 2025 |
Source payment records
|
|||||
| Integra Dermal Regeneration Template Normalized: integra dermal regeneration template |
Device | Integra LifeSciences Corporation | $427.56 | 5 | 2025 |
Source payment records
|
|||||
| PRIMATRIX Normalized: primatrix |
Device | Integra LifeSciences Corporation | $427.56 | 5 | 2025 |
Source payment records
|
|||||
| ELUVIA Normalized: eluvia |
Device | Boston Scientific Corporation | $326.08 | 3 | 2025 |
Source payment records
|
|||||
| ENDURANT IIS Normalized: endurant iis |
Device | Medtronic, Inc. | $313.96 | 5 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $307.68 | 6 | 2025 |
Source payment records
|
|||||
| PURAPLY WOUND MATRIX Normalized: puraply wound matrix |
Device | Organogenesis Inc. | $291.45 | 6 | 2025 |
Source payment records
|
|||||
| HYDRO LEMAITRE VALVULOTOME Normalized: hydro lemaitre valvulotome |
Device | LeMaitre Vascular, Inc. | $192.14 | 3 | 2025 |
Source payment records
|
|||||
| DIAMONDBACK PERIPHERAL Normalized: diamondback peripheral |
Device | Abbott Laboratories | $161.08 | 2 | 2025 |
Source payment records
|
|||||
| APLIGRAF Normalized: apligraf |
Device | Organogenesis Inc. | $155.93 | 4 | 2025 |
Source payment records
|
|||||
| SEISMIQ Prime Catheter_PI Normalized: seismiq prime catheter pi |
Device | Boston Scientific Corporation | $147.92 | 3 | 2025 |
Source payment records
|
|||||
| ARTEGRAFT VASCULAR GRAFT Normalized: artegraft vascular graft |
Device | LeMaitre Vascular, Inc. | $136.68 | 3 | 2025 |
Source payment records
|
|||||
| GORE TAG Thoracic Branch Endoprosthesis Normalized: gore tag thoracic branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $134.82 | 1 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $128.00 | 1 | 2025 |
Source payment records
|
|||||
| Surgiphor Normalized: surgiphor |
Device | Davol Inc. | $115.69 | 1 | 2025 |
Source payment records
|
|||||
| AFFINITY Normalized: affinity |
Medical Supply | Organogenesis Inc. | $113.24 | 1 | 2025 |
Source payment records
|
|||||
| ARISTA Normalized: arista |
Device | Davol Inc. | $107.85 | 1 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $105.34 | 2 | 2025 |
Source payment records
|
|||||
| TRIVEX SYSTEM Normalized: trivex system |
Device | LeMaitre Vascular, Inc. | $102.16 | 1 | 2025 |
Source payment records
|
|||||
| TREO ABDOMINAL STENT-GRAFT SYSTEM Normalized: treo abdominal stent graft system |
Device | Bolton Medical Inc | $95.95 | 2 | 2025 |
Source payment records
|
|||||
| GORE TAG Conformable Thoracic Endoprosthesis Normalized: gore tag conformable thoracic endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $93.47 | 1 | 2025 |
Source payment records
|
|||||
| EXCLUDER Conformable AAA Endoprosthesis with Active Control Normalized: excluder conformable aaa endoprosthesis with active control |
Device | W. L. Gore & Associates, Inc. | $89.32 | 2 | 2025 |
Source payment records
|
|||||
| MicroMatrix Normalized: micromatrix |
Device | Integra LifeSciences Corporation | $66.46 | 1 | 2025 |
Source payment records
|
|||||
| Flexitouch Plus Normalized: flexitouch plus |
Device | Tactile Systems Technology Inc | $56.96 | 3 | 2025 |
Source payment records
|
|||||
| Nimbl Normalized: nimbl |
Device | Tactile Systems Technology Inc | $56.96 | 3 | 2025 |
Source payment records
|
|||||
| AngioJet Ultra 5000A Normalized: angiojet ultra 5000a |
Device | Boston Scientific Corporation | $42.36 | 1 | 2025 |
Source payment records
|
|||||
| XENOSURE BIOLOGIC PATCH Normalized: xenosure biologic patch |
Device | LeMaitre Vascular, Inc. | $28.90 | 1 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $22.44 | 1 | 2025 |
Source payment records
|
|||||
| COVERA Normalized: covera |
Device | Becton, Dickinson and Company | $14.94 | 1 | 2025 |
Source payment records
|
|||||
| ABRE Normalized: abre |
Device | Medtronic, Inc. | $4.30 | 1 | 2025 |
Source payment records
|
|||||
| ZENITH Normalized: zenith |
Device | Cook Medical LLC | $3.45 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14,440.20 · 118 records | Boston Scientific Corporation | ABRE, AFFINITY, APLIGRAF, ARISTA, ARTEGRAFT VASCULAR GRAFT, AngioJet Ultra 5000A, COVERA, Cytal, DIAMONDBACK PERIPHERAL, ELUVIA, ENDURANT IIS, ESPRIT, EXCLUDER Conformable AAA Endoprosthesis with Active Control, EkoSonic, Flexitouch Plus, GORE TAG Conformable Thoracic Endoprosthesis, GORE TAG Thoracic Branch Endoprosthesis, General - Therapies, HYDRO LEMAITRE VALVULOTOME, Indigo System, Integra, Integra Dermal Regeneration Template, MicroMatrix, Nimbl, PRIMATRIX, PURAPLY WOUND MATRIX, Penumbra System, SEISMIQ Prime Catheter_PI, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Surgiphor, TREO ABDOMINAL STENT-GRAFT SYSTEM, TRIVEX SYSTEM, VALIANT CAPTIVIA, XENOSURE BIOLOGIC PATCH, ZENITH, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error